| Trial ID: | L3952 |
| Source ID: | NCT01889914
|
| Associated Drug: |
2 Different Procedures Of Administration Of Insulin
|
| Title: |
TReatment by Insulin Continuous Infusion in Type 2 DIAbetes
|
| Acronym: |
TRICIDIA2
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes
|
| Interventions: |
DRUG: 2 different procedures of administration of insulin
|
| Outcome Measures: |
Primary: changes from baseline in insulinoresistance measured by biological tests of hyperinsulinemic euglycemic clamp in the two groups of treatment 6 months after the start of the treatment., baseline and six months after the begining of the study | Secondary: change from baseline in the hyperglycemia time spent during basal and prandial period with continuous glucose monitoring tool at 6 months, baseline and six months after the beginning of the study|change from baseline in HbA1c in the two groups of treatment at three, six, nine and twelve months, baseline and three, six, nine, twelve months|change from baseline in quality of life measured with questionnaires at 6 months, baseline and 6 months|change from baseline in weight at three, six, nine and twelve months in the two groups., baseline and three, six, nine and twelve months
|
| Sponsor/Collaborators: |
Sponsor: Centre Hospitalier Universitaire Dijon
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
60
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
|
| Start Date: |
2012-01
|
| Completion Date: |
2015-09
|
| Results First Posted: |
|
| Last Update Posted: |
2013-07-01
|
| Locations: |
CHU, Dijon, 21000, France
|
| URL: |
https://clinicaltrials.gov/show/NCT01889914
|
